Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-17

Clinical Trial Update: Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia [NA]

View source ↗

Summary

This is a completed clinical trial evaluating piperacillin/tazobactam for empirical therapy of febrile neutropenia. Phase information is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Febrile, Neutropenia | NA | Status: COMPLETED